Influence of hydrophobicity on the antimicrobial activity of helical antimicrobial peptides: a study focusing on three mastoparans
- PMID: 39617871
- DOI: 10.1007/s11030-024-11046-w
Influence of hydrophobicity on the antimicrobial activity of helical antimicrobial peptides: a study focusing on three mastoparans
Abstract
Hydrophobicity is crucial for the interaction between amphipathic antimicrobial peptides and microbial pathogens. However, it is difficult to fully understand the impact of this factor because the biological functions are also influenced by other structural properties, including peptide length, net charge, hydrophilicity, secondary structure, and hydrophobic moment. This study compares three natural antimicrobial peptides-mastoparan C, mastoparan-AF, and mastoparan L-where hydrophobicity varies but other structural features remain nearly identical. Mastoparan C, the most hydrophobic peptide, displays the highest helical content and hemolytic activity, whereas mastoparan-AF, with slightly lower hydrophobicity, demonstrates superior selectivity. In contrast, mastoparan L, the least hydrophobic peptide, exhibits the weakest antimicrobial potency and lowest hemolytic activity, despite showing the least self-assembly. Overall, this study suggests that optimal hydrophobicity, rather than the highest value, enhances antimicrobial efficacy while minimizing hemolytic activity.
Keywords: Antimicrobial peptides; Hydrophobicity; Mastoparans; Structure–activity relationships.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest: We have no conflict of interest to declare. Informed consent: Not relevant.
References
-
- Lazzaro BP, Zasloff M, Rolff J (2020) Antimicrobial peptides: application informed by evolution. Science 368:eaau5480. https://doi.org/10.1126/science.aau5480 - DOI - PubMed - PMC
-
- Shi G, Kang X, Dong F et al (2022) DRAMP 3.0: an enhanced comprehensive data repository of antimicrobial peptides. Nucleic Acids Res 50:D488–D496. https://doi.org/10.1093/nar/gkab651 - DOI - PubMed
-
- Li W, Separovic F, O’Brien-Simpson NM, Wade JD (2021) Chemically modified and conjugated antimicrobial peptides against superbugs. Chem Soc Rev 50:4932–4973. https://doi.org/10.1039/D0CS01026J - DOI - PubMed
-
- Luong HX, Thanh TT, Tran TH (2020) Antimicrobial peptides—advances in development of therapeutic applications. Life Sci 260:118407. https://doi.org/10.1016/j.lfs.2020.118407 - DOI - PubMed - PMC
-
- Mahlapuu M, Björn C, Ekblom J (2020) Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit Rev Biotechnol 40:978–992. https://doi.org/10.1080/07388551.2020.1796576 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
